1. UBS Lux Equity Fund Biotech USD
UBS Lux Equity Fund Biotech USD P-acc
Fee
2.25%
ISIN
LU0069152568
Holdings
10
BGF World Healthscience A2
Fee
2.17%
ISIN
LU0122379950
Holdings
10
We have information about 14 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Vertex (9.9) and Moderna (9.21). In comparison with BGF World Healthscience, we have 20 holdings where UnitedHealth is the largest holding (8.2), followed by Eli Lilly (7.01) and Novo Nordisk (6.67).
Here we compare the holdings in UBS Lux Equity Fund Biotech USD and BGF World Healthscience.
| UBS Lux Equity Fund Biotech USD | BGF World Healthscience |
|---|---|
|
10.04 % |
 8.2 % |
|
9.9 % |
7.01 % |
|
9.21 % |
 6.67 % |
|
6.54 % |
 3.99 % |
|
5.52 % |
3.67 % |
|
4.66 % |
3.61 % |
|
4.32 % |
3.58 % |
|
4.13 % |
 3.05 % |
|
3.75 % |
3.02 % |
|
3.28 % |
  2.98 % |
The list of fund holdings was last updated on April 17, 2025.
